Evidence map›Paper›PMID 37667758›Full record

ArticleIJU case reports2023

Composite pheochromocytoma associated with neurofibromatosis type 1.

Akira Tachibana, Kota Iida, Yoshitaka Itami, Masaya Hashimura, Yukinari Hosokawa, Kiyohide Fujimoto

Open access · goldAbstract readCase Reports
In one paragraph

Article in IJU case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Akira TachibanaDepartment of Urology Tane General Hospital Osaka Japan.
Kota IidaDepartment of Urology Tane General Hospital Osaka Japan.ORCID https://orcid.org/0000-0001-7804-9128
Yoshitaka ItamiDepartment of Urology Tane General Hospital Osaka Japan.
Masaya HashimuraDepartment of Urology Tane General Hospital Osaka Japan.
Yukinari HosokawaDepartment of Urology Tane General Hospital Osaka Japan.
Kiyohide FujimotoDepartment of Urology Nara Medical University Nara Japan.
Tane General Hospital · JPNara Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Composite pheochromocytoma is a rare tumor, occurring in only 3% of pheochromocytomas. We report a case of composite pheochromocytoma with neurofibromatosis type 1. Case presentation: A 42-year-old man was referred to our department for further evaluation of an incidentally detected right adrenal tumor. He was a patient at another hospital for neurofibromatosis type 1. The serum and urinary catecholamine levels exceeded the normal range. Abdominal computed tomography and magnetic resonance imaging showed a 2.8 cm diameter right adrenal tumor, and Conclusion: Preoperative diagnosis of composite pheochromocytoma-ganglioneuroma is difficult; therefore, histopathological examination is necessary for a definitive diagnosis. Pheochromocytoma management requires lifelong follow-up.

Indexed as

adrenal tumorcomposite pheochromocytomaganglioneuromaneurofibromatosis type 1

Identifiers

PMID37667758
PMCPMC10475341
OpenAlexW4382862597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.